Last updated: April 5, 2024
Sponsor: Assiut University
Overall Status: Active - Recruiting
Phase
2/3
Condition
Acute Pain
Treatment
Epidural analgesia with bupivacaine and dexmedetomidine
Clinical Study ID
NCT05781854
Dexmedetomidine in normallabor
Ages 18-45 Female Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age 18 - 45 years
- Scheduled for normal vaginal delivery
- ASA physical status ӀI-IӀӀ.
- Singleton non-complicated pregnancy.
- At least 36 weak of gestation.
- Vertex presentation.
Exclusion
Exclusion Criteria:
- Patient refusal to epidural analgesia.
- History of cardiac, liver, or kidney diseases.
- History of allergy to amide local anesthetics or study medications.
- Any neurological problem.
- History of chronic opioid analgesic use.
- Any contraindication of regional anesthesia.
- Evidence of intrauterine growth restriction or fetal compromise.
- Failed or unsatisfactory analgesic block.
- Body mass index ≥40 kg/m2
Study Design
Total Participants: 60
Treatment Group(s): 1
Primary Treatment: Epidural analgesia with bupivacaine and dexmedetomidine
Phase: 2/3
Study Start date:
May 29, 2023
Estimated Completion Date:
October 01, 2025
Study Description
Connect with a study center
Assiut university hospital
Assiut, 71111
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.